<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND &amp; AIMS: Barrett <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> (BA+) and <z:mp ids='MP_0008010'>gastric adenocarcinoma</z:mp> comprise a related group of <z:hpo ids='HP_0002664'>neoplasms</z:hpo> that nevertheless have some distinct clinicopathologic characteristics </plain></SENT>
<SENT sid="1" pm="."><plain>This study aimed at defining critical molecular abnormalities that may underlie differences between BA+ and <z:mp ids='MP_0008010'>gastric adenocarcinomas</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: We used comparative genomic hybridization for the analyses of 34 xenografts of <z:mp ids='MP_0009308'>adenocarcinomas</z:mp> that arose from esophageal or gastric origin </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: <z:hpo ids='HP_0000001'>All</z:hpo> <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e>, except one, exhibited DNA copy number alterations </plain></SENT>
<SENT sid="4" pm="."><plain>Losses in 4q and 14q and gains at 2p and 17q were more frequent in proximal (esophageal, gastroesophageal junction [GEJ], and cardia) <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> than in distal (body and antrum) <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> (P &lt;or= 0.050) </plain></SENT>
<SENT sid="5" pm="."><plain>These changes were significantly higher in BA+ compared with distal <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> (P &lt;or= 0.040) </plain></SENT>
<SENT sid="6" pm="."><plain>In addition, losses in 5q and gains at 20q were significantly higher in BA+ than in distal <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> (P &lt;or= 0.040) </plain></SENT>
<SENT sid="7" pm="."><plain>Losses in 5q and 8p and gains at 2q, 6p, 12p, and 20q were significantly more frequent in BA+ <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> (P &lt;or= 0.050) than in GEJ and <z:e sem="disease" ids="C0018809" disease_type="Neoplastic Process" abbrv="">cardiac tumors</z:e> without associated <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> </plain></SENT>
<SENT sid="8" pm="."><plain>Additionally, losses in 14q, which were common in proximal <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e>, were more often seen in BA+ (P = 0.100) than in other proximal <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS: Although these <z:mp ids='MP_0009308'>adenocarcinomas</z:mp> share some common genetic alterations, the differences in the DNA copy numbers in BA+ cases suggest that unique genetic alterations may be involved in these <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e>' development </plain></SENT>
</text></document>